Post-Illumination Pupil Response as a Biomarker for Cognition in α-Synucleinopathies

J Parkinsons Dis. 2022;12(2):593-598. doi: 10.3233/JPD-212775.

Abstract

Neurodegenerative processes in the brain are reflected by structural retinal changes. As a possible biomarker of cognitive state in prodromal α-synucleinopathies, we compared melanopsin-mediated post-illumination pupil response (PIPR) with cognition (CERAD-plus) in 69 patients with isolated REM-sleep behavior disorder. PIPR was significantly correlated with cognitive domains, especially executive functioning (r = 0.417, p < 0.001), which was more pronounced in patients with lower dopamine-transporter density, suggesting advanced neurodegenerative state (n = 26; r = 0.575, p = 0.002). Patients with mild neurocognitive disorder (n = 10) had significantly reduced PIPR (smaller melanopsin-mediated response) compared to those without (p = 0.001). Thus, PIPR may be a functional-possibly monitoring-marker for impaired cognitive state in (prodromal) α-synucleinopathies.

Keywords: biomarker; cognition; dopamine-transporter density; executive functioning; melanopsin; post-illumination pupil response; pupillometry; α-synucleinopathies.

Publication types

  • Letter

MeSH terms

  • Biomarkers
  • Cognition
  • Humans
  • Lighting
  • Parkinson Disease*
  • Pupil / physiology
  • Reflex, Pupillary / physiology
  • Retinal Ganglion Cells / physiology
  • Synucleinopathies*

Substances

  • Biomarkers